Effect of dalcetrapib plus pravastatin on lipoprotein metabolism and high-density lipoprotein composition and function in dyslipidemic patients: Results of a phase IIb dose-ranging study-Reference-Cited by-同舟云学术

Effect of dalcetrapib plus pravastatin on lipoprotein metabolism and high-density lipoprotein composition and function in dyslipidemic patients: Results of a phase IIb dose-ranging study

Published:2012-03 Issue:3 Volume:163 Page:515-521.e3
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Ballantyne Christie M.,Miller Michael,Niesor Eric J.,Burgess Tracy,Kallend David,Stein Evan A.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference42 articles.

1. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials;Baigent;Lancet,2010

2. High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport;Assmann;Atherosclerosis,1996

3. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study;Castelli;JAMA,1986

4. High-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: the Lipid Research Clinics Coronary Primary Prevention Trial;Gordon;Circulation,1986

5. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study;Sharrett;Circulation,2001

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-Density Lipoprotein Subclasses and Their Role in the Prevention and Treatment of Cardiovascular Disease: A Narrative Review;International Journal of Molecular Sciences;2024-07-18

2. High‐Density Lipoprotein Particle Concentration and Size Predict Incident Coronary Artery Disease Events in a Cohort With Type 1 Diabetes;Journal of the American Heart Association;2024-07-16

3. HDL Particle Concentration and Size Predict Incident Coronary Artery Disease Events in People with Type 1 Diabetes;2023-11-07

4. Dalcetrapib and anacetrapib increase apolipoprotein E-containing HDL in rabbits and humans;Journal of Lipid Research;2023-01

5. Environmental Factors Modifying HDL Functionality;Current Medicinal Chemistry;2021-07-14